Zinc‐Binding Groups Modulate Selective Inhibition of MMPs
- 8 May 2008
- journal article
- research article
- Published by Wiley in ChemMedChem
- Vol. 3 (5), 812-820
- https://doi.org/10.1002/cmdc.200700290
Abstract
The need for selective matrix metalloproteinase (MMP) inhibition is of interest because of the range of pathologies mediated by different MMP isoforms. The development of more selective MMP inhibitors (MMPi) may help to overcome some of the undesired side effects that have hindered the clinical success of these compounds. In an effort to devise new approaches to selective inhibitors, herein we describe several novel MMPi and show that their selectivity is dependent on the nature of the zinc‐binding group (ZBG). This is in contrast to most current MMPi, which obtain isoform selectivity solely from the peptidomimetic backbone portion of the compound. In the present study, six different hydroxypyrone and hydroxypyridinone ZBGs were appended to a common biphenyl backbone and the inhibition efficiency of each inhibitor was determined in vitro (IC50 values) against MMP‐1, ‐2, ‐3, ‐7, ‐8, ‐9, ‐12, and ‐13. The results show that the selectivity profile of each inhibitor is different as a result of the various ZBGs. Computational modeling studies were used to explain some trends in the observed selectivity profiles. To assess the importance of the ZBG in a biological model, two of the semiselective, potent MMPi (and one control) were evaluated using an isolated perfused rat heart system. Hearts were subjected to ischemia reperfusion injury, and recovery of contractile function was examined. In this model, only one of the two MMPi showed significant and sustained heart recovery, demonstrating that the choice of ZBG can have a significant effect in a relevant pathophysiological endpoint.This publication has 59 references indexed in Scilit:
- Matrix metalloproteinases and the regulation of tissue remodellingNature Reviews Molecular Cell Biology, 2007
- Recent advances in MMP inhibitor designCancer and Metastasis Reviews, 2006
- Heterocyclic zinc-binding groups for use in next-generation matrix metalloproteinase inhibitors: potency, toxicity, and reactivityJBIC Journal of Biological Inorganic Chemistry, 2005
- Coumarin-Based Chemosensors for Zinc(II): Toward the Determination of the Design Algorithm for CHEF-Type and Ratiometric ProbesInorganic Chemistry, 2005
- From Model Complexes to Metalloprotein Inhibition: A Synergistic Approach to Structure-Based Drug DiscoveryAngewandte Chemie-International Edition, 2003
- From Model Complexes to Metalloprotein Inhibition: A Synergistic Approach to Structure‐Based Drug DiscoveryAngewandte Chemie, 2003
- X‐ray structure of a novel matrix metalloproteinase inhibitor complexed to stromelysinProtein Science, 2001
- Metal and pH Dependence of Heptapeptide Catalysis by Human MatrilysinBiochemistry, 1996
- The origin of matrix metalloproteinases and their familial relationshipsFEBS Letters, 1991
- A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomasNature, 1990